Albert Einstein Cancer Center
BronxNet - November 17, 2021
Ulrich Steidl, M.D., Ph.D., talks about his NCI Outstanding Investigator Award and $7 million grant that will support his research on the molecular and cellular mechanisms underlying myelodysplastic syndromes and acute myeloid leukemia. Dr. Steidl is co-director of the Blood Cancer Institute and associate director of basic science at the Albert Einstein Cancer Center, and professor of cell biology and of medicine and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research at Einstein.
Professor Ulrich Steidl Describes Research As “A Team Sport”
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
November 21, 2018
New Rochelle Patch.com interviews Ulrich Steidl, M.D., Ph.D., about his genetics research that could lead to new treatment options for acute myeloid leukemia patients. Dr. Steidl is assistant professor of medicine and of cell biology and The Diane and Arthur B. Belfer Faculty Scholar in Cancer Research.
September 7, 2012